CP CRANBURY PHARMACEUTICALS
LIVE

Serial Number

98397270

Owner

CRANBURY PHARMACEUTICALS

Attorney

Cathy Kodroff

Filing Date

Feb 8, 2024

Add to watchlist:

No watchlists yet
View on USPTO

CP CRANBURY PHARMACEUTICALS Trademark

Serial Number: 98397270

CP CRANBURY PHARMACEUTICALS is a trademark filed by CRANBURY PHARMACEUTICALS on February 8, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

CRANBURY PHARMACEUTICALS (4 trademarks)

2031 US Highway 130
Monmouth Junction, NJ 08852

Entity Type: 16

Trademark Details

Filing Date

February 8, 2024

Registration Date

Not Registered

Published for Opposition

July 15, 2025

Goods & Services

Prescription and non-prescription generic pharmaceutical medicines and preparations for the treatment of cold and allergy symptoms, respiratory disease, asthma and chronic lung disease, upper respiratory symptoms, coughs, diabetes, high cholesterol, high blood pressure, bacterial infections, malaria, hyperuricemia, gout, central nervous system disorders, namely, narcolepsy and attention deficit hyperactivity disorder, for the treatment of autism, schizophrenia, bipolar disorder, convulsions, epilepsy, nausea, vomiting, pruritus, for inducing sedation, for pain relief, and for anti-inflammation

Distributorship of prescription and non-prescription generic pharmaceutical medicines and preparations

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 7, 2026 EXRA
SOU EXTENSION 1 GRANTED
Mar 6, 2026 EX1G
SOU EXTENSION 1 FILED
Mar 6, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 6, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 9, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 9, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 10, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 10, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 10, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 10, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 10, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 28, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Apr 28, 2025 ERFR
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 28, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 28, 2025 XELR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 28, 2025 GNFN
FINAL REFUSAL E-MAILED
Jan 28, 2025 GNFR
FINAL REFUSAL WRITTEN
Jan 28, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 23, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 25, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 25, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 25, 2024 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 24, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 24, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 3, 2024 GNRN
NON-FINAL ACTION E-MAILED
Sep 3, 2024 GNRT
NON-FINAL ACTION WRITTEN
Sep 3, 2024 CNRT
ASSIGNED TO EXAMINER
Sep 3, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 7, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 7, 2024 NWOS
NEW APPLICATION ENTERED
Feb 8, 2024 NWAP